New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
20:25 EDTJNJ, JNJ, JPM, JPM, GS, GS, CMA, CMA, JBHT, JBHT, CBSH, CBSH, WWW, WWW, WAFD, WAFD, WABC, WABCNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $1.55; JPMorgan (JPM), consensus $1.29; Goldman Sachs (GS), consensus $3.05; Comerica (CMA), consensus 76c; JB Hunt (JBHT), consensus 79c; Commerce Bancshares (CBSH), consensus 68c; Wolverine World Wide (WWW), consensus 27c; Washington Federal (WAFD), consensus 37c; Westamerica Bancorp. (WABC), consensus 58c.
News For JNJ;JPM;GS;CMA;JBHT;CBSH;WWW;WAFD;WABC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 20, 2014
06:30 EDTJPM, GSSenate panel says banks could influence commodity prices, NY Times says
Subscribe for More Information
November 19, 2014
17:06 EDTWAFDWashington Federal coverage assumed with a Neutral at Sterne Agee
Subscribe for More Information
12:38 EDTJPM, GSSenate Homeland Security & Government Affairs Committee to hold a hearing
Subscribe for More Information
09:04 EDTJNJJohnson & Johnson submits NDA for three-month paliperidone palmitate
Janssen Research & Development, a Johnson & Johnson company, announced the submission of a New Drug Application, or NDA, for three-month atypical antipsychotic paliperidone palmitate to the FDA. The NDA seeks approval for the medication as a treatment for schizophrenia in adults. If approved, it will be the first and only long-acting atypical antipsychotic that has a four times a year dosing schedule.
07:51 EDTJPM, GSClearing House Payments Company to hold a conference
Subscribe for More Information
07:37 EDTJPMCitigroup to hold a conference
Global Financial Conference is being held in Singapore on November 19-20.
06:30 EDTJNJJohnson & Johnson, Boston Scientific trial set to start tomorrow, Reuters says
Subscribe for More Information
06:24 EDTGSGoldman Sachs currency trader dismissed, NY Times reports
Subscribe for More Information
November 18, 2014
09:01 EDTJPMJPMorgan announces municipal bond agreement with LPL Financial
JPMorgan Chase & Co. (JPM) announced that it has signed an agreement with LPL Financial (LPLA) to provide access to new issue municipal bonds to LPL financial advisors. Under the agreement, LPL will be a preferred retail dealer for J.P. Morgan, further expanding the investment bankís distribution channels for new issue municipal bonds.
November 17, 2014
10:06 EDTJPMSears Canada, JPMorgan Chase announce changes to credit card program
Subscribe for More Information
07:16 EDTJNJMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
06:18 EDTJPMJPMorgan reports October net credit losses 2.26% vs. 2.24% last month
Reports October delinquency rate 1.34% vs. 1.30% last month.
November 16, 2014
17:42 EDTJPMJPMorgan settles mineral rights suit in Texas, Bloomberg says
JPMorgan settled a lawsuit by Texas mineral-rights owners that accused the bank of negotiating "sweetheart deals" with oil company clients to cheat them out of $681M in compensation, says Bloomberg. Beneficiaries of the South Texas Syndicate Trust alleged that JPMorgan entered into favorable deals for its commercial banking clients on the trustís rights in the Eagle Ford, added Bloomberg. Reference Link
November 14, 2014
16:21 EDTJNJOn The Fly: Closing Wrap
Subscribe for More Information
14:53 EDTJNJCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
November 13, 2014
16:28 EDTJNJGeron announces global strategic collaboration with Janssen Biotech
Geron (GERN) announced that the company has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, a Johnson & Johnson (JNJ) company, to develop and commercialize, imetelstat, Geron's telomerase inhibitor product candidate, for oncology, including hematologic malignancies, and other human therapeutics uses. Imetelstat is a modified oligonucleotide that is currently in early phase clinical development for myelofibrosis, or MF, and may have activity in other hematologic myeloid malignancies such as myelodysplastic syndrome, or MDS, and acute myelogenous leukemia, or AML. Under the terms of the agreement, Geron will receive an initial payment of $35M due after the applicable waiting periods under the Hart-Scott Rodino Act and is eligible to receive additional payments up to a potential total of $900M for the achievement of development, regulatory and commercial milestones, as well as royalties on worldwide net sales. Certain regulatory, development, manufacturing and promotional activities will be managed through a joint governance structure, with Janssen responsible for operational implementation of these activities. All sales will be booked by Janssen.
11:54 EDTJNJJanssen announces FDA approved sNDA for INVEGA SUSTENNA
Subscribe for More Information
10:44 EDTJNJMallinckrodt news on generic Concerta positive for Actavis, says BMO Capital
Subscribe for More Information
08:47 EDTGSGoldman Sachs management to meet with JMP Securities
Subscribe for More Information
07:38 EDTJPMBloomberg Link to hold a conference
The Year Ahead: 2015 is being held in Washington, D.C. with a pre-conference dinner on November 13 followed by company presentations on November 14,
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use